RICHARD R HOWELL

Allopathic & Osteopathic Physicians|Family Medicine FLORENCE, SC NPI 1790743722

General Payments — all program years on this page

$1,419.90

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 95
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $314.28 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $314.2819

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $175.6110
Novo Nordisk AS $49.403
PFIZER INC. $47.953
CVRx Inc. $25.242
Janssen Pharmaceuticals, Inc $16.081

By program year

Program yearAmountRecords
2018 $131.5010
2019 $176.8010
2020 $109.867
2021 $205.0214
2022 $159.0510
2023 $323.3925
2024 $314.2819

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078176243 Janssen Pharmaceuticals, Inc $16.08 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086895891 Novartis Pharmaceuticals Corporation $15.92 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086895893 Novartis Pharmaceuticals Corporation $15.28 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086895895 Novartis Pharmaceuticals Corporation $13.17 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086895897 Novartis Pharmaceuticals Corporation $14.02 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086895899 Novartis Pharmaceuticals Corporation $11.29 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086895901 Novartis Pharmaceuticals Corporation $15.61 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086895903 Novartis Pharmaceuticals Corporation $19.69 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086895905 Novartis Pharmaceuticals Corporation $23.19 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086895909 Novartis Pharmaceuticals Corporation $24.41 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086895911 Novartis Pharmaceuticals Corporation $23.03 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097009352 Novo Nordisk Inc $14.78 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097548696 Novo Nordisk Inc $15.12 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097760131 Novo Nordisk Inc $19.50 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128594149 CVRx, Inc. $11.18 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128594151 CVRx, Inc. $14.06 07/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130945864 PFIZER INC. $16.60 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131810301 PFIZER INC. $16.42 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131928708 PFIZER INC. $14.93 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.